Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entry

被引:8
作者
Koenigs, Christoph
Pustowka, Anette
Irving, James
Kessel, Christoph
Klich, Katharina
Wegner, Valerie
Rowley, Merrill J.
Mackay, Ian R.
Kreuz, Wolfhart
Griesinger, Christian
Dietrich, Ursula
机构
[1] Georg Speyer Haus, Biomed Res Inst, D-60596 Frankfurt, Germany
[2] JW Geothe Univ, Dept Pediat, Hs32, Frankfurt, Germany
[3] Univ Oxford, Wellcome Trust Human Genet, Dvi Struct Biol, Oxford, England
[4] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia
[5] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany
关键词
HIV-1; entry; CCR5; epitopes; phage display;
D O I
10.1038/sj.icb.7100077
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CCR5 is a chemokine receptor that mediates entry of human immunodeficiency virus-1 (HIV-1). Two monoclonal antibodies (mAbs) that block HIV-1 entry, 3A9 and 5C7, were used to select peptide mimotopes of sequences on CCR5 from phage displayed peptide libraries. The selected mimotofpes comprised motifs at the N-terminus and on the first and third extracellular loops (ECL1 and ECL3) of CCR5. Amino acids in these motifs were exchanged for alanines by site-directed mutagenesis (sdm) in the cDNA for human CCR5. Ensuing effects on antibody binding to CCR5, cellular entry of HIV-1 and chemokine-induced signalling were analysed by transfection of mutant cDNAs into HEK293.CD4 cells. For both mAbs, fluorescence-activated cell sorting analysis was used to define overlapping conformational epitopes on CCR5 at the N-terminus, on ECL1 and ECL3. Mutation of the N-terminal motif (10)YD11 prevented HIV-1 entry into transfected cells as judged by single round infection assays with R5 and R5X4 HIV-1 isolates, as did mutation of the motif (96)FG(97) in ECL1, whereas mutation of the motif (RLD276)-R-274 in ECL3 had only a minor effect. None of the motifs in CCR5 relevant to HIV-1 entry disrupted chemokine-induced signalling. Thus, peptide mimotopes of conformational contact sites of CCR5 with the paratope of mAbs 3A9 and 5C7 represent sites on CCR5 that are essential for HIV-1 entry. Structural knowledge of these mimotopes could help elucidate the nature of the interaction between CCR5 and HIV-1, and thus the derivation of specific inhibitors of entry of HIV-1 into susceptible cells without interference with chemokine signalling.
引用
收藏
页码:511 / 517
页数:7
相关论文
共 39 条
[1]   Grafting segments from the extracellular surface of CCR5 onto a bacteriorhodopsin transmembrane scaffold confers HIV-1 coreceptor activity [J].
Abdulaev, NG ;
Strassmaier, TT ;
Ngo, T ;
Chen, RW ;
Luecke, H ;
Oprian, DD ;
Ridge, KD .
STRUCTURE, 2002, 10 (04) :515-525
[2]   Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5 [J].
Agrawal, L ;
VanHorn-Ali, Z ;
Berger, EA ;
Alkhatib, G .
BLOOD, 2004, 103 (04) :1211-1217
[3]   Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines [J].
Atchison, RE ;
Gosling, J ;
Monteclaro, FS ;
Franci, C ;
Digilio, L ;
Charo, IF ;
Goldsmith, MA .
SCIENCE, 1996, 274 (5294) :1924-1926
[4]   HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor [J].
Bieniasz, PD ;
Fridell, RA ;
Aramori, I ;
Ferguson, SSG ;
Caron, MG ;
Cullen, BR .
EMBO JOURNAL, 1997, 16 (10) :2599-2609
[5]   Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells [J].
Bomsel, Morgane ;
Pastori, Claudia ;
Tudor, Daniela ;
Alberti, Chiara ;
Garcia, Severine ;
Ferrari, Davide ;
Lazzarin, Adriano ;
Lopalco, Lucia .
AIDS, 2007, 21 (01) :13-22
[6]   Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1 [J].
Doranz, BJ ;
Lu, ZH ;
Rucker, J ;
Zhang, TY ;
Sharron, M ;
Cen, YH ;
Wang, ZX ;
Guo, HH ;
Du, JG ;
Accaviti, MA ;
Doms, RW ;
Peiper, SC .
JOURNAL OF VIROLOGY, 1997, 71 (09) :6305-6314
[7]   An overview of the determinants of CCR5 and CXCR4 co-receptor function [J].
Dragic, T .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :1807-1814
[8]   Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry [J].
Dragic, T ;
Trkola, A ;
Lin, SW ;
Nagashima, KA ;
Kajumo, F ;
Zhao, L ;
Olson, WC ;
Wu, LJ ;
Mackay, CR ;
Allaway, GP ;
Sakmar, TP ;
Moore, JP ;
Maddon, PJ .
JOURNAL OF VIROLOGY, 1998, 72 (01) :279-285
[9]   A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry [J].
Farzan, M ;
Vasilieva, N ;
Schnitzler, CE ;
Chung, S ;
Robinson, J ;
Gerard, NP ;
Gerard, C ;
Choe, H ;
Sodroski, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) :33516-33521
[10]   Tyrosine-sulfated peptides functionally reconstitute a CCR5 variant lacking a critical amino-terminal region [J].
Farzan, M ;
Chung, S ;
Li, WH ;
Vasilieva, N ;
Wright, PL ;
Schnitzler, CE ;
Marchione, RJ ;
Gerard, C ;
Gerard, NP ;
Sodroski, J ;
Choe, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) :40397-40402